MBIO · Mustang Bio Inc
United States · RS rating 15 · As of 2026-11-03
| Price | 0.41 USD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 33 / 20 / 12 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 7 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -14.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +71.0% |
| Market cap (USD) | $5.8M |